Skip to main content

  • Analysis: Surgical Explant of THVs After TAVR Brings Higher Risk vs. Redo SAVR

    BOSTON — Surgical explantation of transcatheter heart valves (THVs) after transcatheter aortic valve replacement (TAVR) confers a higher risk of mortality and other clinical outcomes compared with redo surgical aortic valve replacement (SAVR), a new analysis shows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details